Form 4: Zivo Bioscience Director Boosts Stake

Zivo Bioscience Director and 10% owner Christopher D. Maggiore purchased 1,766 shares of common stock at $8.49 per share.

Summary

• Christopher D. Maggiore, a Director and 10% owner of Zivo Bioscience, Inc. (ZIVO), acquired 1,766 shares of common stock.
• The transaction occurred on January 14, 2026, at a price of $8.49 per share.
• Following this purchase, Maggiore beneficially owns a total of 519,292 shares of Zivo Bioscience common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant insider (Director and 10% owner) increasing their stake in the company, which typically signals confidence in future performance or undervaluation.

Positives

• A Director and 10% owner, Christopher D. Maggiore, increased his stake in Zivo Bioscience, Inc. by purchasing 1,766 shares.
• Insider buying often signals confidence from management regarding the company's future prospects and valuation.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, but insider purchases can be interpreted as a positive signal for future prospects.

Industry Context

Insider purchases, particularly by significant stakeholders like a Director and 10% owner, are generally viewed as a positive indicator within the market, suggesting that those closest to the company believe its shares are undervalued or expect positive developments. This action aligns with a broader trend where insider confidence can influence investor sentiment.

Related Party Transactions

• Christopher D. Maggiore, a Director and 10% owner of Zivo Bioscience, Inc., purchased 1,766 shares of common stock, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock and future performance.
• The transaction, made under a Rule 10b5-1(c) plan, indicates a pre-planned acquisition strategy by the insider.

Key Dates

Recommendation

The purchase of shares by a Director and 10% owner, Christopher D. Maggiore, signals strong insider confidence in Zivo Bioscience, Inc. This type of insider buying often suggests that management believes the stock is undervalued or anticipates positive future developments, making it a bullish indicator for potential investors.

Keywords

Zivo Bioscience, ZIVO, insider trading, stock purchase, director, 10% owner, Form 4, equity acquisition